We are live on
!
Find out more
11A
10-15 Associates Portfolio holdings
AUM
$516M
1-Year Est. Return
7.62%
This Fund
S&P 500
This Quarter
Est. Return
+0.5%
1 Year Est. Return
+7.62%
3 Year Est. Return
+32.98%
5 Year Est. Return
+79.47%
10 Year Est. Return
–
AUM
$307M
AUM Growth
+$15.6M
(+5.4%)
Cap. Flow
+$13.7M
Cap. Flow
% of AUM
4.46%
Top 10 Holdings %
Top 10 Hldgs %
40.55%
Holding
104
New
11
Increased
50
Reduced
34
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$7.3M |
| 2 |
Chevron
CVX
|
+$3.31M |
| 3 |
Coca-Cola
KO
|
+$3.16M |
| 4 |
VanEck Agribusiness ETF
MOO
|
+$1.55M |
| 5 |
MetLife
MET
|
+$1.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$7.72M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$1.6M |
| 3 |
United Parcel Service
UPS
|
+$1.51M |
| 4 |
Clorox
CLX
|
+$655K |
| 5 |
NextEra Energy
NEE
|
+$97.8K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 18.2% |
| 2 | Miscellaneous | 15.92% |
| 3 | Industrials | 11.67% |
| 4 | Communication Services | 10.35% |
| 5 | Consumer Staples | 8.19% |
Similar funds
IA
CPF
AIM
VCP
LWS
FA
CCM
KFA
10-15 Associates's Q1 2014 Portfolio in Review
As of Q1 2014, 10-15 Associates held 104 positions worth $307M, up 5.4% from $291M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
10-15 Associates deployed $13.7M of net new capital in Q1 2014, opening 11 new positions and adding to 50 existing holdings. Its largest new stake was ConocoPhillips: 109,049 shares worth $7.67M.
By sector, the portfolio is most concentrated in Energy at 18% of assets, up from 17% a quarter earlier, followed by Miscellaneous and Industrials.
On the sell side, the largest reduction was iShares Biotechnology ETF, an estimated $1.6M trimmed.
- 10-15 Associates's largest Q1 2014 buy was ConocoPhillips: 109,049 shares worth $7.67M.
- 10-15 Associates added most to Chevron in Q1 2014, an estimated $3.31M increase.
- 10-15 Associates's biggest Q1 2014 reduction was iShares Biotechnology ETF, cutting an estimated $1.6M.
- 10-15 Associates fully exited Royal Dutch Shell PLC ADS Class A in Q1 2014, selling an estimated $7.72M.
- 10-15 Associates's ten largest holdings make up 41% of its $307M portfolio in Q1 2014.
- 10-15 Associates opened 11 new positions and closed 3 in Q1 2014.
- 10-15 Associates's portfolio value rose 5.4% quarter-over-quarter to $307M.
Based on 10-15 Associates's 13F filing for Q1 2014, filed 6 May 2014.